This study examined the effects of sublingually administered nitroglycerin on forearm resistance vessels in normal subjects (n = 9) and in patients with congestive heart failure (n = 8). Forearm blood flow was measured with a strain-gauge plethysmograph and forearm vascular resistance was calculated. To assess the magnitude of reflex forearm vasoconstriction triggered by decreased central venous pressure after sublingual nitroglycerin, lower body negative pressure (LBNP) was applied to produce a comparable decrease in central venous pressure to that after nitroglycerin. The change in forearm vascular resistance during LBNP was compared with that after nitroglycerin. In normal subjects, LBNP increased but nitroglycerin did not change forearm vascular resistance. In patients with congestive heart failure neither nitroglycerin nor LBNP changed forearm vascular resistance. The direct vasodilator effect of nitroglycerin on forearm resistance vessels assessed by the difference between the change in forearm vascular resistance produced by nitroglycerin and that during LBNP tended to be less in patients with congestive heart failure than in normal subjects, which might have resulted from decreased vasodilator capacity of resistance vessels in patients with congestive heart failure. Changes in forearm vascular resistance with a cold pressor test were not different between normal subjects and patients with congestive heart failure. These data suggest that in normal subjects, nitroglycerin does not alter forearm vascular resistance because its dilator effect is offset by reflex vasoconstriction. In patients with congestive heart failure, reflex vasoconstriction is impaired but the direct vasodilator effect of nitroglycerin also tends to be reduced, so that as a net effect forearm vascular resistance is not altered.
assessed by examining the forearm vascular response to lower body negative pressure (LBNP), which is adjusted to produce a comparable decrease in central venous pressure to that with nitroglycerin. Thus, by comparing the change in forearm vascular resistance produced by nitroglycerin with that during LBNP, one may assess the direct vasodilator effect of nitroglycerin on forearm resistance vessels.
In this study, we assessed the direct vasodilator as well as indirect reflex vasoconstrictor effect of nitroglycerin administered sublingually on forearm resistance vessels in patients with congestive heart failure and normal subjects. There are several reasons for this study. First, it is important to demonstrate that sublingually administered nitroglycerin is not a selective venodilator but dilates the arteries as well as the veins.
The arterial dilator effect of nitroglycerin, which may be offset normally by reflex vasoconstriction, may manifest when baroreflex function is impaired. Results of a recent study suggest that reflex forearm vasocon-Vol. 72, No. 4, October 1985 striction in response to a decrease in central venous pressure is impaired in patients with congestive heart failure. 7 Thus the effects of nitroglycerin on forearm resistance vessels in patients with congestive heart failure might be different from those in normal subjects because offsetting indirect reflex vasoconstriction may be impaired. Second, it is important to know the effect of nitroglycerin on muscle blood flow because exercise capacity may depend on muscle blood flow.i 1 Failure to alter total vascular resistance by systemically administered nitroglycerin does not necessarily mean that regional vascular resistance is not altered. Although total vascular resistance is not changed by nitroglycerin,2 3 it is conceivable that blood flow to muscles may be altered by the drug. Data in animals suggest that the effect of nitroglycerin on vascular resistance may be different between skeletal muscle and other organs.3
Methods
Subjects. Nine normal subjects (eight men, one woman) and eight patients with congestive heart failure (seven men, one woman) were studied. Ages of normal subjects ranged from 30 to 65 years (mean 42 + 4) and those of patients with congestive heart failure ranged from 33 to 55 years (mean 43 + 3 years). Ages of these two groups were not different. Normal subjects were free of any cardiovascular disease by history, physical examination, and electrocardiographic studies. All patients with congestive heart failure had clinical, roentgenographic, and hemodynamic evidence of congestive heart failure. Five patients had rheumatic heart disease, two had congestive cardiomyopathy, and one had ischemic heart disease. All of these patients were in NYHA functional class III or higher. All patients had cardiomegaly on chest roentgenogram. Five patients underwent cardiac catheterization within 3 weeks after the study, which showed the elevated mean pulmonary capillary wedge or pulmonary diastolic pressure (average 31 ± 4 mm Hg). Five patients were on a maintenance dosage of digoxin when the study was done. Five patients were taking furosemide and one prazosin. None were on nitrates. Informed written consent was obtained from all subjects.
Measurement of forearm blood flow. The study was done with the subjects in the supine positior. and in the postabsorptive state. Forearm blood flow was meast\ed with a mercury-in-Silastic strain-gauge plethysmograph with a venous occlusion technique as previously described.`The strain gauge was placed approximately 5 cm below the antecubital crease. Forearm blood flow (ml/min/ 100 ml of forearm) was calculated from the rate of increase in forearm volume while venous return from the forearm was prevented by inflating the cuff at the upper arm. The pressure in the venous occlusion or congesting cuff was 40 mm Hg. Circulation to the hand was arrested by inflating a cuff around the wrist. The wrist cuff was inflated before the determination of forearm blood flow and continuously throughout the measurements. Blood pressure was measured with a sphygmomanometer in the other arm. Forearm vascular resistance was calculated by dividing the difference in the mean blood pressure (mm Hg) and central venous pressure (mm Hg) by the forearm blood flow. These values are expressed as units throughout this report. Mean blood pressure was calculated by adding one-third of the pulse pressure to the diastolic pressure. An average of five to eight flow measurements made at 15 sec intervals was used for later analysis.
LBNP. The lower half of the subject's body below the iliac crest was enclosed in a box sealed and connected to a vacuum. To examine reflex forearm vasoconstriction, the pressure inside the box was lowered below the atmospheric pressure, which decreased venous return and caused reflex forearm vasoconstriction. A catheter was inserted into an antecubital vein, which was advanced into the superior vena cava; central venous pressure was measured with a pressure transducer (Toyo Baldwin,
Cold pressor test. Ice was placed on the subject's forehead for 45 sec and forearm blood flow was measured throughout. Blood pressure was measured before and at the end of the cold pressor test. Forearm vascular resistance at the termination of cold stimulus was compared with that at control.
Protocols. After stable blood pressure and central venous pressure were obtained, forearm blood flow at control was measured. The subjects were then given one tablet of sublingual nitroglycerin (0.3 mg). Forearm blood flow was recorded at every 15 sec, central venous pressure was recorded continuously, and blood pressure was measured every 30 sec until a stable and maximal reduction in central venous pressure was obtained, which took about 5 min. After administration of nitroglycerin we waited for at least 60 min, by which time central venous pressure and blood pressure returned to the control values. LBNP was then applied to produce a comparable reduction in central venous pressure to that observed after sublingual nitroglycerin. LBNP was continued for the same duration as that required to reach the maximal reduction in central venous pressure after nitroglycerin. Statistical analysis. Statistical analysis was done with paired and unpaired t tests; p < .05 was considered significantly different. All values were expressed as mean + SEM.
Results
Basal hemodynamic values are shown in table 1. Heart rate was faster (p < .01) and central venous pressure was higher (p < .001) in patients with congestive heart failure than in normal subjects. Neither resting forearm blood flow nor forearm vascular resistance was different between patients with congestive heart failure and normal subjects.
Representative recordings of forearm blood flow in response to nitroglycerin and LBNP in a normal subject are illustrated in figure 1 . Nitroglycerin produced no significant changes in forearm blood flow or forearm vascular resistance, whereas LBNP with a comparable reduction in central venous pressure to that after nitroglycerin decreased forearm blood flow and increased forearm vascular resistance.
Responses to nitroglycerin and LBNP are summarized in table 2. In normal subjects, nitroglycerin decreased central venous pressure (p < .01) but did not alter blood pressure, forearm blood flow, or forearm vascular resistance. LBNP decreased central venous pressure (p < .01) to an extent that was not different from that with nitroglycerin. However, LBNP decreased forearm blood flow (p < .01) and increased forearm vascular resistance (p < .0025) . In patients with congestive heart failure nitroglycerin decreased central venous pressure (p < .001). This reduction in central venous pressure with nitroglycerin was larger than that in normal subjects (p < .025). Nitroglycerin did not change forearm blood flow or forearm vascular resistance. LBNP decreased central venous pressure (p < .01) to an extent that was not different from that with nitroglycerin. LBNP did not change forearm blood flow or forearm vascular resistance.
Control
Responses to the cold pressor test are given in table 3. Cold stimuli increased mean blood pressure (p < .001 for both groups) and forearm vascular resistance in normal subjects as well as in patients with congestive heart failure (p < .05 for normal subjects and p < .025 for patients with congestive heart failure). However, the increase in mean blood pressure as well as in forearm vascular resistance in response to the cold pressor test was not different between two groups.
Discussion
The effects of nitroglycerin on resistance vessels are likely to result from an interaction between the direct vasodilator effect and indirect reflex vasoconstriction triggered by the reduction in central venous pressure. In this study we assumed that the magnitude of reflex vasoconstriction that should have occurred after sublingual administration of nitroglycerin might be as-Vol. 72, No. 4, October 1985 sessed by measuring reflex vasoconstriction during LBNP when LBNP was adjusted to produce a comparable reduction in central venous pressure to that observed after nitroglycerin. This assumption is valid only when the gain of the vasoconstrictor reflex is not altered by nitroglycerin. However, results of a previous study from our laboratory indicated that the relationship between central venous pressure and forearm vascular resistance during LBNP is not altered by nitroglycerin. We should also consider the possibility that the magnitude of an adaptation of the baroreflex during persistent stimulation might have been different between nitroglycerin and LBNP. If so, the assumption may not be reasonable. The development of an adaptation is time-dependent. 12 However, in this study we examined forearm vascular responses to nitroglycerin and to LBNP at a similar time interval. It has not been shown that nitroglycerin alters the rate or magnitude of an adaptation of the reflex mechanisms. Thus it is unlikely that the magnitude of an adaptation of the reflex mechanisms was different between nitroglycerin and LBNP. On the basis of these considerations, we assumed that the direct vasodilator effect of nitroglycerin on forearm resistance vessels might be approximated by obtaining the difference between the change in forearm vascular resistance during LBNP and that with nitroglycerin.
The results of this study indicate that in normal subjects, nitroglycerin did not alter but LBNP increased forearm vascular resistance with a comparable reduction in central venous pressure. Changes in forearm vascular resistance during LBNP were significantly greater (p < .05) than those with nitroglycerin (table 2), suggesting that nitroglycerin exerted the direct vasodilator effect on forearm resistance vessels. These results suggest that nitroglycerin did not alter forearm vascular resistance in normal subjects because its potent direct vasodilator effect on forearm resistance vessels was offset by reflex vasoconstriction triggered by the reduction in central venous pressure. In patients with congestive heart failure, neither nitroglycerin nor LBNP alftered forearm vascular resistance. Thus the mechanisms by which nitroglycerin did not alter forearm vascular resistance appear to be different between normal subjects and patients with congestive heart failure.
An attenuation of vasoconstrictor response to a decrease in central venous pressure has been reported previously in patients with congestive heart failure.7 750 Failure to respond to LBNP in patients with congestive heart failure was not caused by the inability for forearm resistance vessels to respond to vasoconstrictor stimuli, since the vasoconstrictor response to the cold pressor test was not altered (table 3) . Abnormal responses to LBNP in patients with congestive heart failure were probably related to an impairment of arterial and/or cardiopulmonary baroreflexes.7 Five of eight patients with congestive heart failure were taking digitalis when the study was done. However, impaired reflex forearm vasoconstriction was probably not caused by digitalis because digitalis has been shown to augment but not attenuate the gain of baroreflex control of forearm resistance vessels in response to LBNP.7 ' The direct vasodilator effect of nitroglycerin on forearm resistance vessels assessed by the difference between changes in forearm vascular resistance during LBNP and those with nitroglycerin tended to be smaller (p < . 1) in patients with congestive heart failure than in normal subjects. Decreased vasodilator capac-CIRCULATION ity of resistance vessels has been shown in animals'4 as well as in patients with congestive heart failure.8 It has been shown that impaired vasodilator capacity of resistance vessels is caused by the increase in sodium content of the vessels and interstitial edema.8 Thus, in patients with congestive heart failure, reflex vasoconstriction was impaired but the direct vasodilator effect of nitroglycerin also tended to be reduced, so that as a net effect forearm vascular resistance was not altered.
It is important to know whether vasodilator drugs increase blood flow to muscle in patients with congestive heart failure, since exercise capacity may depend on muscle blood flow.8 It is not possible to predict the effect of nitroglycerin on regional vascular beds from its effect on total vascular resistance. Flaim et al. '5 have shown in an animal study that nitroglycerin has no significant effect on blood flow or vascular resistance in skeletal muscle in heart failure. The results Vol. 72, No. 4, October 1985 of this study indicate that sublingually administered nitroglycerin in patients with congestive heart failure did not alter blood flow or vascular resistance in the forearm.
Because forearm blood flow is composed of both muscle and skin blood flow,'6'9 we cannot determine the changes in blood flow in muscle from changes in forearm blood flow. However, previous studies have suggested that responses to nitroglycerin at rest are not markedly different between muscle and skin in normal subjects as well as in patients with heart failure.4 '5 Thus we believe that proportional changes in muscle blood flow in response to nitroglycerin may be similar to those in forearm blood flow.
In summary, nitroglycerin did not alter forearm vascular resistance either in normal subjects or in patients with congestive heart failure. In normal subjects the direct vasodilator effect of nitroglycerin on forearm resistance vessels appeared to be offset by indirect reflex vasoconstriction triggered by the decrease in central venous pressure. In patients with congestive heart failure, indirect reflex vasoconstriction was impaired but the direct vasodilator effect of nitroglycerin also tended to be reduced, so that as a net effect forearm vascular resistance was not altered.
